Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of GBP 99.10 billion. The enterprise value is 132.78 billion.
Market Cap | 99.10B |
Enterprise Value | 132.78B |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | May 9, 2025 |
Share Statistics
Current Share Class | 5.69B |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.97% |
Shares Change (QoQ) | +0.12% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 16.27 and the forward PE ratio is 8.28.
PE Ratio | 16.27 |
Forward PE | 8.28 |
PS Ratio | 2.05 |
PB Ratio | 1.42 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 15.32.
EV / Earnings | 21.80 |
EV / Sales | 2.86 |
EV / EBITDA | 7.25 |
EV / EBIT | 10.76 |
EV / FCF | 15.32 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.
Current Ratio | 1.26 |
Quick Ratio | 0.88 |
Debt / Equity | 0.69 |
Debt / EBITDA | 2.55 |
Debt / FCF | 5.56 |
Interest Coverage | 5.57 |
Financial Efficiency
Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.
Return on Equity (ROE) | 8.62% |
Return on Assets (ROA) | 4.79% |
Return on Invested Capital (ROIC) | 6.52% |
Return on Capital Employed (ROCE) | 9.58% |
Revenue Per Employee | 595,698 |
Profits Per Employee | 75,178 |
Employee Count | 81,000 |
Asset Turnover | 0.29 |
Inventory Turnover | 1.47 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.29% in the last 52 weeks. The beta is 0.50, so Pfizer's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | -15.29% |
50-Day Moving Average | 23.57 |
200-Day Moving Average | 26.35 |
Relative Strength Index (RSI) | 53.04 |
Average Volume (20 Days) | 416,241 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.00 |
Income Statement
In the last 12 months, Pfizer had revenue of GBP 48.25 billion and earned 6.09 billion in profits. Earnings per share was 1.07.
Revenue | 48.25B |
Gross Profit | 35.91B |
Operating Income | 12.70B |
Pretax Income | 5.71B |
Net Income | 6.09B |
EBITDA | 18.01B |
EBIT | 12.70B |
Earnings Per Share (EPS) | 1.07 |
Balance Sheet
The company has 13.38 billion in cash and 48.20 billion in debt, giving a net cash position of -34.82 billion.
Cash & Cash Equivalents | 13.38B |
Total Debt | 48.20B |
Net Cash | -34.82B |
Net Cash Per Share | n/a |
Equity (Book Value) | 70.01B |
Book Value Per Share | 12.28 |
Working Capital | 7.27B |
Cash Flow
In the last 12 months, operating cash flow was 10.81 billion and capital expenditures -2.14 billion, giving a free cash flow of 8.67 billion.
Operating Cash Flow | 10.81B |
Capital Expenditures | -2.14B |
Free Cash Flow | 8.67B |
FCF Per Share | n/a |
Margins
Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.
Gross Margin | 74.42% |
Operating Margin | 26.33% |
Pretax Margin | 11.82% |
Profit Margin | 12.62% |
EBITDA Margin | 37.34% |
EBIT Margin | 26.33% |
FCF Margin | 17.96% |
Dividends & Yields
This stock pays an annual dividend of 1.32, which amounts to a dividend yield of 5.60%.
Dividend Per Share | 1.32 |
Dividend Yield | 5.60% |
Dividend Growth (YoY) | 0.03% |
Years of Dividend Growth | 1 |
Payout Ratio | 121.49% |
Buyback Yield | -0.97% |
Shareholder Yield | 4.64% |
Earnings Yield | 6.14% |
FCF Yield | 8.75% |
Stock Splits
The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.
Last Split Date | Jul 1, 1999 |
Split Type | Forward |
Split Ratio | 3 |
Scores
Pfizer has an Altman Z-Score of 2.22. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.22 |
Piotroski F-Score | n/a |